Table 2.
Obstetric, neonatal, and infant outcomes assessed by the C-VIPER and the PIPER
| Obstetrica | Neonatal (< 29 days of age)a | Infant (29 days–12 months of age) |
|---|---|---|
| Spontaneous abortion | Major congenital malformations | Developmental milestones (motor, cognitive, language, social-emotional, and mental health skills) at 6, 9, and 12 months of ageb |
| Antenatal bleeding | Low birth weight | Height |
| Gestational diabetes | Neonatal death | Weight |
| Gestational hypertension | Neonatal encephalopathy | Failure to thrive |
| Intrauterine growth restriction | Neonatal infections | Medical conditions during the first 12 months of life |
| Postpartum hemorrhage | Neonatal acute kidney injury | COVID-19 |
| Fetal distress | Preterm birth | |
| Uterine rupture | Respiratory distress in the newborn | |
| Placenta previa | Small for gestational age | |
| Chorioamnionitis | Stillbirth | |
| Caesarean delivery | COVID-19 | |
| COVID-19 |
COVID-19 coronavirus disease 2019, C-VIPER COVID-19 Vaccines International Pregnancy Registry, PIPER Pregistry International Pregnancy Exposure Registry
aBased on case definitions developed by the Global Alignment of Immunization safety Assessment in pregnancy network [21], except COVID-19
bAs assessed by the Caregiver-Reported Early Development Instrument[23]